Research

African Woman using laptop at home at night

In addition to helping patients find the optimal therapeutic approach to their mental health concerns, we provide patients and other mental healthcare providers with resources and research to expand their knowledge of effective treatment methods and groundbreaking developments in the world of psychiatry. Explore our library of content below.

Does Pyridoxine Control Behavioral Symptoms in Adult Patients Treated with Levetiracetam? Taoufik Alsaadi

Behavioral symptoms are known side effects of levetiracetam. Previous case series in children and adolescents have demonstrated the potential effect of pyridoxine in ameliorating these symptoms. We retrospectively reviewed the charts of 51 patients treated with pyridoxine to control agitation and irritability following the introduction of levetiracetam.

Read Full Article
Advice to Young Psychiatrists From a Very Old One Allen Frances, MD

I recently came across this compelling tweet: “An open question on mental health as a junior psychiatrist. What do you think I should learn and focus on to be a better doctor and advocate for my patients?” Could there possibly be a better question for all people starting out in any field to ask themselves, and others, as they embark on their careers? The 140-character limit imposed by Twitter forced me to offer only a brief reply containing five scant snippets of advice. This troubled me-his serious request deserves a more serious response. Here it is-the 50 most important things I have learned in my 50 years studying psychiatry:

Read Full Article
The Best Foods for Vitamins and Minerals Matthew Sloan

The best approach to ensure you get a variety of vitamins and minerals, and in the proper amounts, is to adopt a broad healthy diet. This involves an emphasis on fruits and vegetables, whole grains, beans and legumes, low-fat protein, and dairy products. The good news is that many common foods contain multiple mineral and vitamin sources, so it is easy to meet your daily needs from everyday meals.

Read Full Article
How to End Migranes Mark Hyman , MD

MORE THAN 10 MILLION Americans have migraines creating a burden of mostly unnecessary suffering. These severe, nearly disabling headaches can occur anywhere from once a year to three to four times a week. They can last from hours to days. They are often associated with an aura, light sensitivity, nausea, vomiting, and severe throbbing pain on one or both sides of the head. Migraines are even associated with stroke-like symptoms or paralysis in some cases.

Read Full Article
Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids in the Treatment of Core Symptoms of Autism Spectrum Disorder Hajar Mazahery

We evaluated the efficacy of vitamin D (VID), omega-3 long chain polyunsaturated fatty acids (omega-3 LCPUFA, OM), or both (VIDOM) on core symptoms of ASD. New Zealand children with ASD (n = 73; aged 2.5-8.0 years) received daily 2000 IU vitamin D3, 722 mg docosahexaenoic acid, both, or placebo.

Read Full Article
Open Dialogue: A New Approach to Mental Healthcare | Psychology Today Dr. Tom Stockmann, Psychiatrist

The development of Open Dialogue is linked to evidence of its superiority to normal treatment of acute psychosis. After 5 years (1992–1997) of Open Dialogue treatment in Lapland, 81 % of participants had no remaining psychotic symptoms and 81% had returned to full employment. Only 35 % had used antipsychotic drugs (Seikkula et al., 2006). Similar results emerged from Tornio between 2003 and 2005. In the UK, only 20% of people diagnosed with schizophrenia would be expected to be symptom free after 5 years, with close to 100% of all patients with psychosis receiving antipsychotics.

Read Full Article
Questions and Answers about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study — All Medication Levels

The overall goal of the STAR*D trial was to assess the effectiveness of depression treatments in patients diagnosed with major depressive disorder, in both primary and specialty care settings. It is the largest and longest study ever conducted to evaluate depression treatment. Each of the four levels of the study tested a different medication or medication combination. The primary goal of each level was to determine if the treatment used during that level could adequately treat participants’ major depressive disorder (MDD). Those who did not become symptom-free could proceed to the next level of treatment.

Read Full Article
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia Dr. Beng-Choon Ho

Progressive brain volume changes in schizophrenia are thought to be due principally to the disease. However, recent animal studies indicate that antipsychotics, the mainstay of treatment for schizophrenia patients, may also contribute to brain tissue volume decrement. Because antipsychotics are prescribed for long periods for schizophrenia patients and have increasingly widespread use in other psychiatric disorders, it is imperative to determine their long-term effects on the human brain.

Read Full Article